BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10910089)

  • 1. Neurologic examination abnormalities in schizophrenia with and without a history of alcoholism.
    Allen DN; Goldstein G; Forman SD; Keshavan MS; van Kammen DP; Sanders RD
    Neuropsychiatry Neuropsychol Behav Neurol; 2000 Jul; 13(3):184-7. PubMed ID: 10910089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of insight in schizophrenia, bipolar I disorder, and depressive disorders with and without comorbid alcohol use disorder.
    Yen CF; Chen CC; Cheng CP; Yen CN; Lin HC; Ko CH; Yen JY; Chen CS
    Psychiatry Clin Neurosci; 2008 Dec; 62(6):685-90. PubMed ID: 19068005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive functioning in dually diagnosed middle aged and elderly patients with alcoholism and schizophrenia.
    Mohamed S; Bondi MW; Kasckow JW; Golshan S; Jeste DV
    Int J Geriatr Psychiatry; 2006 Aug; 21(8):711-8. PubMed ID: 16862606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebellar dysfunction in neuroleptic naive schizophrenia patients: clinical, cognitive, and neuroanatomic correlates of cerebellar neurologic signs.
    Ho BC; Mola C; Andreasen NC
    Biol Psychiatry; 2004 Jun; 55(12):1146-53. PubMed ID: 15184033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognition, symptomatology, and functional skills in older alcohol-abusing schizophrenia patients.
    Bowie CR; Serper MR; Riggio S; Harvey PD
    Schizophr Bull; 2005 Jan; 31(1):175-82. PubMed ID: 15888435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological and sensory gating deficits related to remote alcohol abuse history in schizophrenia.
    Thoma RJ; Hanlon FM; Miller GA; Huang M; Weisend MP; Sanchez FP; Waldorf VA; Jones A; Smith A; Formoso MJ; Cañive JM
    J Int Neuropsychol Soc; 2006 Jan; 12(1):34-44. PubMed ID: 16433942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognitive function in schizophrenia with comorbid posttraumatic stress disorder.
    Duke LA; Allen DN; Ross SA; Strauss GP; Schwartz J
    J Clin Exp Neuropsychol; 2010 Aug; 32(7):737-51. PubMed ID: 20198528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confirmatory factor analysis of the Neurological Evaluation Scale in unmedicated schizophrenia.
    Sanders RD; Allen DN; D Forman S; Tarpey T; Keshavan MS; Goldstein G
    Psychiatry Res; 2005 Jan; 133(1):65-71. PubMed ID: 15698678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Schizophrenic disorders--does cognitive dysfunction relate to characteristics of course and psychopathology of the illness?].
    Wciórka J; Bembenek A; Hintze B; Kühn-Dymecka A
    Psychiatr Pol; 2006; 40(5):867-84. PubMed ID: 17217232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mismatch negativity deficits are associated with poor functioning in schizophrenia patients.
    Light GA; Braff DL
    Arch Gen Psychiatry; 2005 Feb; 62(2):127-36. PubMed ID: 15699289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The convergence of neuropsychological testing and clinical ratings of cognitive impairment in patients with schizophrenia.
    Harvey PD; Serper MR; White L; Parrella MJ; McGurk SR; Moriarty PJ; Bowie C; Vadhan N; Friedman J; Davis KL
    Compr Psychiatry; 2001; 42(4):306-13. PubMed ID: 11458305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
    Altshuler LL; Ventura J; van Gorp WG; Green MF; Theberge DC; Mintz J
    Biol Psychiatry; 2004 Oct; 56(8):560-9. PubMed ID: 15476685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensory-perceptual dysfunction in patients with schizophrenia and comorbid alcoholism.
    Goldstein G; Allen DN; Sanders RD
    J Clin Exp Neuropsychol; 2002 Dec; 24(8):1010-6. PubMed ID: 12650227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological impairment in deficit vs. non-deficit schizophrenia.
    Cascella NG; Testa SM; Meyer SM; Rao VA; Diaz-Asper CM; Pearlson GD; Schretlen DJ
    J Psychiatr Res; 2008 Sep; 42(11):930-7. PubMed ID: 18021807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological impairment in patients with schizophrenia and evidence of hyponatremia and polydipsia.
    Torres IJ; Keedy S; Marlow-O'Connor M; Beenken B; Goldman MB
    Neuropsychology; 2009 May; 23(3):307-14. PubMed ID: 19413445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
    Huguelet P; Nicastro R; Zanello A
    Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic validation of conjoint schizophrenia and alcoholism.
    Alterman AI; Ayre FR; Williford WO
    J Clin Psychiatry; 1984 Jul; 45(7):300-3. PubMed ID: 6735989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.